Does Invokamet have a boxed warning?
Boxed warningWARNING: LACTIC ACIDOSIS
Cases of metformin-associated lactic acidosis reported after approval have resulted in death, low body temperature, low blood pressure and slow heart rhythms that resist treatment. It often starts subtly, with only vague symptoms such as feeling unwell, muscle aches, trouble breathing, sleepiness and abdominal pain. It was marked by blood lactate above 5 mmol/L, anion gap acidosis without ketones, a raised lactate to pyruvate ratio, and metformin levels generally above 5 mcg/mL. Risk factors include kidney impairment, certain drugs (for example carbonic anhydrase inhibitors such as topiramate), age 65 or older, a radiology study with contrast, surgery and other procedures, low-oxygen states such as acute heart failure, heavy alcohol use, liver impairment and mitochondrial diseases. If it is suspected, Invokamet is stopped immediately and supportive care is started in a hospital; prompt hemodialysis is recommended.
When does the label say to call your doctor?
From the Medication Guide that comes with Invokamet:
- Signs of lactic acidosis: stop taking Invokamet and call your healthcare provider right away.
- Signs of ketoacidosis: stop taking Invokamet and call your health care provider or get medical help right away, and if possible check for ketones in your urine or blood.
- New pain or tenderness, sores, ulcers or infections in your leg or foot: call your healthcare provider right away.
- Pain or tenderness, redness or swelling in the genital area or the area between the genitals and the anus, with fever or feeling unwell: the label advises prompt medical attention (section 17).
- Symptoms of a serious allergic reaction: stop taking Invokamet and call your healthcare provider right away or go to the nearest hospital emergency room.
What are the most common Invokamet side effects?
These are the label's own numbers from the Adverse Reactions section. Where the label compares with placebo (a dummy treatment), both columns are shown, so you can see how much more often a reaction happened on Invokamet.
One monotherapy trial and three add-on trials with metformin, metformin and a sulfonylurea, or metformin and pioglitazone; 1,275 people took canagliflozin with metformin. Percentages were weighted by trials. Female and male genital yeast infection rates use the number of women or men in each group.
Show all 8 reactionsHide table
| Adverse reaction | Placebo (N=646) | Canagliflozin 100 mg (N=833) | Canagliflozin 300 mg (N=834) |
|---|---|---|---|
| Urinary tract infections | 3.8% | 5.9% | 4.4% |
| Increased urination | 0.7% | 5.1% | 4.6% |
| Thirst | 0.1% | 2.8% | 2.4% |
| Constipation | 0.9% | 1.8% | 2.4% |
| Nausea | 1.6% | 2.1% | 2.3% |
| Female genital mycotic infections (women: N=312, 425, 430) | 2.8% | 10.6% | 11.6% |
| Vulvovaginal pruritus (women) | 0.0% | 1.6% | 3.2% |
| Male genital mycotic infections (men: N=334, 408, 404) | 0.7% | 4.2% | 3.8% |
Other numbers in the Adverse Reactions section
- Section 6.1Abdominal pain was also more common on canagliflozin 100 mg (1.8%) and 300 mg (1.7%) than on placebo (0.8%).
- Section 6.1When canagliflozin and metformin were started together, diarrhea was 4.2% in the combination groups vs 1.7% on either one alone.
Show 2 more findingsShow fewer
- Section 6.1In the three metformin add-on trials, side effects were similar to Table 3, with none added.
- Section 6.1In CREDENCE (diabetic kidney disease), lower limb amputation was 12.3 vs 11.2 events per 1,000 patient-years on canagliflozin 100 mg vs placebo, and low blood pressure 2.8% vs 1.5%.
What serious risks does the Invokamet label warn about?
The Warnings and Precautions part of the label lists these. Each line gives the label's heading and what it means in plain words.
- Section 5.1Lactic acidosis. The boxed-warning risk. Starting Invokamet is not recommended with an eGFR below 45, and it is not used below 30. It is stopped around some iodinated contrast scans, paused while food and fluids are restricted, stopped in shock, heart attack, sepsis or acute heart failure with low oxygen, and avoided with liver disease.
- Section 5.2Ketoacidosis. Ketoacidosis can happen whatever the blood sugar. Ketone checks may be considered in people at risk, and Invokamet is stopped if it is suspected. It is not recommended in type 1 diabetes.
- Section 5.3Lower limb amputation. People are watched for infections or ulcers of the legs and feet, which are treated.
- Section 5.4Volume depletion. Fluid loss may lead to acute kidney injury. Fluid status is checked and corrected before starting in people with kidney problems, older people and people on loop diuretics.
Show 5 more risksShow fewer
- Section 5.5Urinary and genital infections, including Fournier's gangrene. Serious urinary infections, kidney infections, genital yeast infections and a rare serious genital-area infection (Fournier's gangrene) have been reported. Pain, redness or swelling in the genital area with fever or feeling unwell is checked right away.
- Section 5.6Low blood sugar with insulin or a sulfonylurea. A lower dose of insulin or a medicine that makes the body release insulin may be considered.
- Section 5.7Allergic reactions. Invokamet is stopped if an allergic reaction occurs, and the person is watched until it resolves.
- Section 5.8Bone fracture. Factors that add to fracture risk are considered before starting.
- Section 5.9Vitamin B12 deficiency. Metformin may lower vitamin B12. Blood counts are measured yearly and vitamin B12 every 2 to 3 years.
How do I keep track of side effects in Dose Track?
Dose Track has a side-effect log. Each entry records the symptom, a severity (none, mild, moderate, severe or life-threatening), the date and an optional note, and can be tied to a specific dose or logged on its own.
Read moreRead less
The history screen shows what you logged over time, which makes it easier to tell your prescriber when a reaction started and whether it is easing. The app records what you enter; it does not judge whether a symptom is serious. For anything on the label's call-your-doctor list, call your doctor.
Frequently asked questions
What are the most common side effects of Invokamet?
Genital yeast infections, urinary tract infections and increased urination. In women, yeast infections were 10.6% on canagliflozin 100 mg and 11.6% on 300 mg vs 2.8% on placebo (section 6.1, Table 3).
Does Invokamet have a boxed warning?
Yes, for lactic acidosis from the metformin part. It is rare but has caused deaths. Risk factors include kidney or liver problems, age 65 or older, contrast scans, surgery, heavy alcohol use and low-oxygen states (boxed warning and section 5.1).
Does Invokamet cause diarrhea?
When canagliflozin and metformin were started together, diarrhea was 4.2% vs 1.7% on either one alone (section 6.1).
Does Invokamet raise amputation risk?
Lower limb amputation is a warning (section 5.3). In CREDENCE the rate was 12.3 vs 11.2 events per 1,000 patient-years on canagliflozin 100 mg vs placebo (section 6.1).
Can Invokamet cause ketoacidosis?
Yes. It is checked for whatever the blood sugar, and Invokamet is stopped if it is suspected. It is held at least 3 days, if possible, before surgery with long fasting (sections 2.6 and 5.2).
Related pages
- Invokamet dosing schedule from the same label
- Canagliflozin compound guide
- Metformin compound guide
- Free reconstitution calculator
Show similar medicinesShow fewer
Side effects for similar medicines
- Actoplus Metpioglitazone and metformin hydrochloride
- Actospioglitazone
- Admeloginsulin lispro injection 100 units/mL
- Afrezzainsulin human inhalation powder
- Apidrainsulin glulisine injection 100 units/mL
- Baqsimiglucagon nasal powder 3 mg
- Basaglarinsulin glargine 100 units/mL
- Cyclosetbromocriptine mesylate
See also
- Invokana dosing schedule
- I missed my Invokamet dose. What should I do?
- Invokana vs Invokamet: what does adding metformin change?
- Invokana side effects
- Kazano side effects
Track it in Dose Track: GLP-1 tracker, TRT tracker or peptide tracker.
Sources
- INVOKAMET (canagliflozin and metformin hydrochloride) tablets and INVOKAMET XR (canagliflozin and metformin hydrochloride extended-release) tablets, for oral use, prescribing information and Medication Guide. Janssen Pharmaceuticals. DailyMed, version published August 25, 2026. DailyMed setid 6868666b-c25e-40d1-9d1f-306bbe9390c1
What Invokamet is approved forHide
Invokamet combines canagliflozin, an SGLT2 inhibitor, with metformin, a biguanide. Along with diet and exercise, Invokamet and Invokamet XR are approved to improve blood sugar control in adults and children 10 years and older with type 2 diabetes (section 1). In adults with type 2 diabetes the canagliflozin part also lowers the risk of major heart events in established heart disease, and of kidney failure, heart death and heart failure hospital stays in diabetic kidney disease with albuminuria above 300 mg/day. It is not recommended for type 1 diabetes.
This page is what the FDA label says, in plain words. It is not medical advice. Follow your prescriber, and ask them or your pharmacist about anything here.
All side-effect pages · Dosing schedules · Missed dose guides · Compound guides